IFC Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-11,170
Closed -$798K 150
2017
Q4
$798K Sell
11,170
-1,588
-12% -$121K 0.05% 235
2017
Q3
$1.03M Buy
12,758
+1,207
+10% +$92.3K 0.07% 189
2017
Q2
$817K Sell
11,551
-799
-6% -$53.2K 0.06% 204
2017
Q1
$841K Sell
12,350
-982
-7% -$69.1K 0.07% 181
2016
Q4
$949K Sell
13,332
-1,995
-13% -$148K 0.09% 153
2016
Q3
$1.22M Buy
15,327
+1,182
+8% +$96K 0.13% 115
2016
Q2
$1.2M Buy
14,145
+1,434
+11% +$127K 0.14% 111
2016
Q1
$1.2M Sell
12,711
-52,508
-81% -$4.74M 0.15% 98
2015
Q4
$6.6M Buy
65,219
+2,287
+4% +$238K 0.88% 22
2015
Q3
$6.31M Sell
62,932
-3,927
-6% -$436K 0.96% 21
2015
Q2
$8.01M Buy
66,859
+4,434
+7% +$485K 1.16% 17
2015
Q1
$6.3M Buy
62,425
+7,364
+13% +$748K 0.96% 19
2014
Q4
$5.17M Buy
55,061
+346
+0.6% +$35.8K 0.85% 21
2014
Q3
$5.82M Sell
54,715
-95
-0.2% -$9.3K 1.05% 17
2014
Q2
$4.55M Sell
54,810
-4,463
-8% -$347K 0.83% 22
2014
Q1
$4.06M Buy
59,273
+154
+0.3% +$12.1K 0.84% 23
2013
Q4
$4.4M Buy
59,119
+5,837
+11% +$406K 0.93% 22
2013
Q3
$3.38M Buy
53,282
+589
+1% +$35.2K 0.73% 25
2013
Q2
$2.7M Buy
+52,693
New +$2.75M 0.65% 31

Other funds holding GILD

IFC Holdings's GILD Position: Q1 2018 in Review

IFC Holdings sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 11,170 shares — an estimated $798K sold.

IFC Holdings first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $8.01M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • IFC Holdings reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • IFC Holdings sold 11,170 Gilead Sciences shares in Q1 2018, an estimated $798K.
  • IFC Holdings first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • IFC Holdings's Gilead Sciences position peaked at $8.01M in Q2 2015.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.